Skip to Main Content

Paper Details

Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Dig Dis
3
2023
CC-chemokine ligand 2, CCL2, FABP2, Fatty Acid, Fatty Acid Binding Protein 2, NAFLD, Non-alcoholic Fatty Liver Disease, Non-alcoholic fatty liver disease, People, Serum CCL2, Serum FABP2, diabetes, dyslipidemia, fibrosis, hepatocellular carcinoma, inflammatory monocytes, insulin, insulin resistance, liver, liver disease, liver fibrosis, obesity, type 2, patient, patients, people
Author NameAffiliation
David A HumeMater Research-The University of Queensland
David A HumeMater Research-The University of Queensland
  • 1 - 2

Datasets

Release 1.2